Twelve years of experience of acquired hemophilia A: Trials and tribulations in South Australia

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 8, 2009, Pages 769-777

  Tay, Lay ^a   Duncan, Elizabeth ^a   Singhal, Deepak ^a   Al Qunfoidi, Reem ^a   Coghlan, Douglas ^a   Jaksic, Wilfred ^a   Szabo, Ferenz ^b   McRae, Simon ^a   Lloyd, John ^a  

^a Division of Haematology   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

Acquired hemophilia; FVIII autoantibody; Recombinant activated FVII; Rituximab

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AUTOANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; DESMOPRESSIN; HEMOSTATIC AGENT; IMMUNOGLOBULIN G; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; STEROID; VINCRISTINE;

ACQUIRED HEMOPHILIA A; AGE DISTRIBUTION; AGED; AUSTRALIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BLEEDING; BLOOD CLOTTING; CELLULITIS; COMPARTMENT SYNDROME; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL HEMORRHAGE; HEMARTHROSIS; HEMATURIA; HEMOPHILIA A; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; LYMPHOMA; MORTALITY; MULTIPLE SCLEROSIS; MUSCLE HEMATOMA; OUTCOME ASSESSMENT; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROSTATE CANCER; RELAPSE; REMISSION; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SKIN BLEEDING; SURVIVAL; TITRIMETRY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AZATHIOPRINE; FACTOR VIIA; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; SOUTH AUSTRALIA; STEROIDS; TREATMENT OUTCOME;

EID: 77449132898     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1245109     Document Type: Review

References (16)

1. Collins P, Macartney N, Davies R et al. A population based, unselected, consecutive cohort of patients with acquired hemophilia A. Br J Haematol 2004 124 (1) 86-90
2. Collins P W., Hirsch S, Baglin T P. et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007 109 (5) 1870-1877
3. Collins P W. Treatment of acquired hemophilia A. J Thromb Haemost 2007 5 (5) 893-900
4. Franchini M, Lippi G. Acquired factor VIII inhibitors. Blood 2008 112 (2) 250-255
5. Delgado J, Jimenez-Yuste V, Hermandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003 121 21-35
6. Hay C R., Negrier C, Ludlam C A. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicenter study. Thromb Haemost 1997 78 1463-1467
7. Hay C, Brown S, Collins P et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors' Organisation. Br J Haematol 2006 133 591-605
8. Yee T T., Taher A, Pasi K J., Lee C A. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol 2000 22 (5) 275-278
9. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981 45 (3) 200-203
10. Burnet S P., Duncan E M., Lloyd J V., Han P. Acquired haemophilia in South Australia: a case series. Intern Med J 2001 31 (9) 556-559
11. Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 2008 141 149-169
12. Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 2004 103 (12) 4424-4428
13. Abdallah A, Coghlan D W., Duncan E M., Chunilal S D., Lloyd J V. Rituximab-induced long-term remission in patients with refractory acquired hemophilia. J Thromb Haemost 2005 3 (11) 2589-2590
14. Aggarwal A, Grewal R, Green R J. et al. Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia 2005 11 (1) 13-19
15. Lloyd J V., Street A M., Berry E et al. Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand. Aust N Z J Med 1997 27 (6) 658-664
16. Lian E C., Villar M J., Noy L I., Ruiz-Dayao Z. Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone. Am J Hematol 2002 69 294-295